Neuroblastoma congénito

1. Fisher JPH, Tweddle DA. Neonatal neuroblastoma. Semin Fetal Neonatal Med. 2012;17(4):207- 215

2. Louis CU, Shohet JM. Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med. 2015;66:49–63

3. Johnsen JI, Dyberg C, Wickström M. Neuroblastoma: a neural crest derived embryonal malignancy. Front Mol Neurosci. 2019;12:9

4. Gely L, Lugo-Vicente H, Correa-Rivas M, et al. Neonatal sacrococcygeal neuroblastoma nimicking a teratoma. Case Rep Pediatr. 2017;2017:3624847 10.1155/2017/3624847

5. Mahapatra S, Challagundla KB. Cancer, neuroblastoma. StatPearls. Last updated April 24, 2020. Accessed August 2, 2020. http://www.ncbi.nlm.nih.gov/books/NBK448111/

6. Nuchtern JG. Perinatal neuroblastoma. Semin Pediatr Surg. 2006;15(1):10–16

7. Isaacs H Jr. Fetal and neonatal neuroblastoma: retrospective review of 271 cases. Fetal Pediatr Pathol. 2007;26(4):177–184

8. French AE, Grant R, Weitzman S, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther. 2003;74(3):288–294

9. Shohet J, Nuchtern J. Epidemiology, pathogenesis, and pathology of neuroblastoma. https://www.uptodate.com/contents/epidemiology-pathogenesis-and-pathology-of-neuroblastoma. Accessed August 3, 2020

10. Simões-Costa M, Bronner ME. Establishing neural crest identity: a gene regulatory recipe. Development. 2015;142(2):242–257

11. Mundell NA, Labosky PA. Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates. Development. 2011;138(4):641–652

12. Westermann F, Muth D, Benner A, et al. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biology. 2008;9:R150

13. Trigg RM, Turner SD. ALK in neuroblastoma: biological and therapeutic implications. Cancers (Basel). 2018;10(4):E113

14. Pei D, Luther W, Wang W, Paw BH, Stewart RA, George RE. Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models. PLoS Genet. 2013;9(6):e1003533

15. Tonini GP, Capasso M. Genetic predisposition and chromosome instability in neuroblastoma. Cancer Metastasis Rev. 2020;39(1):275–285

16. Carén H, Kryh H, Nethander M, et al. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proc Natl Acad Sci USA. 2010;107(9):4323–4328

17. Westermann F, Schwab M. Genetic parameters of neuroblastomas. Cancer Lett. 2002;184(2):127–147

18. Psarris A, Sindos M, Dimopoulou A, et al. Prenatal diagnosis of adrenal neuroblastoma – differential diagnosis of suprarenal masses in the third trimester of pregnancy. Ultrasound Int Open. 2019;5(3):E93–E95